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We investigated the metabolism of human brown
adipose tissue (BAT) in healthy subjects by deter-
mining its cold-induced and insulin-stimulated
glucose uptake and blood flow (perfusion) using
positron emission tomography (PET) combined with
computed tomography (CT). Second, we assessed
gene expression in human BAT and white adipose
tissue (WAT). Glucose uptake was induced 12-fold
in BAT by cold, accompanied by doubling of perfu-
sion. We found a positive association between
whole-body energy expenditure and BAT perfusion.
Insulin enhanced glucose uptake 5-fold in BAT inde-
pendently of its perfusion, while the effect on WAT
was weaker. The gene expression level of insulin-
sensitive glucose transporterGLUT4was also higher
in BAT as compared to WAT. In conclusion, BAT
appears to be differently activated by insulin and
cold; in response to insulin, BAT displays high
glucose uptake without increased perfusion, but
when activated by cold, it dissipates energy in a
perfusion-dependent manner.
INTRODUCTION
Brown adipose tissue (BAT) is capable of adaptive thermogene-
sis because of the presence of uncoupling protein 1 (UCP1) in
its numerous mitochondria. BAT dissipates energy as heat
in response to stimulation by the sympathetic nervous system
(Cinti, 2006). The existence of active BAT in healthy adult
humans has been debated and was not confirmed until
recently (reviewed by Enerba¨ck, 2010). When using positron
emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glu-
cose ([18F]FDG) tracer, combined with computed tomography272 Cell Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Inc(CT) for diagnostic imaging of metabolically active tumors and
metastases, a confounding symmetrical pattern of increased
metabolism is often observed in the supraclavicular region
(Nedergaard et al., 2007). On the basis of PET/CT-guided biop-
sies from healthy subjects, it was recently established that this
tissue corresponds to metabolically active BAT since it both
presents histological features of BAT and expresses mRNA
and proteins that are expected for BAT (Virtanen et al., 2009).
Whether BAT plays a significant role in human metabolism is
still unclear. However, recent studies indicate that BAT may
be more abundant in leaner individuals (e.g., van Marken Lich-
tenbelt et al., 2009).
To elucidate the characteristics of BAT activation, we studied
a group of 27 healthy adults by using PET/CT imaging with
[15O]H2O and [
18F]FDG as tracers during cold exposure and, in
a warm environment, either with or without insulin stimulation.
We measured perfusion and glucose uptake rates in BAT and
compared them to those in skeletal muscle and subcutaneous
white adipose tissue (WAT). Perfusion rate is generally matched
to the oxygen consumption of a tissue (Segal, 2005), and in the
case of BAT, determination of perfusion rate can be used to
estimate thermogenesis. We found that activation of energy-
consuming BAT by cold leads to an increased perfusion rate
that is associated with whole-body energy expenditure. Classic
brown adipocytes have been shown to share a common origin
with skeletal muscle cells (Seale et al., 2008). While skeletal
muscle is known to be a highly insulin-sensitive tissue, little is
known about the insulin sensitivity of human BAT. This study
was set up to address this issue. Our data suggest that BAT is
a highly insulin-sensitive tissue type, since the insulin-stimulated
glucose uptake rate in BAT is not significantly different from that
in skeletal muscle.
RESULTS
Cold Exposure and Glucose Uptake
In this study, the adipose tissue in which the glucose uptake rate
was higher than 3.0 mmol/100 g/min during cold exposure was.
Figure 1. Glucose Uptake
(A) Control [18F]FDG-PET/CT image showing minimal BAT activity.
(B) Cold exposure [18F]FDG-PET/CT image showing cold-activated BAT.
(C) Insulin stimulation [18F]FDG-PET/CT image showing insulin-mediated BAT activity.
(D) Glucose uptake rates in BAT, subcutaneous neckWAT, subcutaneous abdominal WAT, VAT, and skeletal muscle determined under control conditions, during
cold exposure, and during insulin stimulation. Results are expressed as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. (A)–(C) from left to
right: transaxial, coronal and sagittal views. The grayscale refers to Hounsfield units of the CT image. Arrows indicate supraclavicular adipose depot.
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chosen after qualitative interpretation of PET/CT images and
determination of BAT glucose uptake rate under control condi-
tions, where the rate was always lower than 1.7 mmol/100 g/min.
Metabolic activation of BAT was detected in 19 out of 27
subjects (70%) in cold exposure [18F]FDG-PET/CT scans. Active
BAT was mostly found in the supraclavicular area but also in
paraspinal and para-aortic regions, the axillary depot, the medi-
astinum, and close to the adrenal glands in conjunction with
supraclavicular uptake (data not shown). The estimated mass
of detected active BAT ranged from 9 to 90 g, the mean mass
being 34 ± 22 g. No significant differences in BAT activation
could be found between males and females. Only the subjects
with cold-activated supraclavicular BAT were included in the
further analysis of BAT metabolism.
Cold-induced BAT glucose uptake rate was determined and
compared to WAT, visceral adipose tissue (VAT), and skeletal
muscle glucose uptake rates. This comparison was considered
important because different tissues may contribute unequally
to cold-induced changes in glucose metabolism.
The BAT glucose uptake rate was markedly increased (0.9 ±
0.4 versus 9.1 ± 5.1 mmol/100 g/min, p = 0.002) by cold exposure
(Figures 1A and 1B). Glucose uptake rate in BAT was increased
on average by a factor of 12 in response to cold. However, the
subcutaneous abdominal WAT glucose uptake rate did not
change with cold exposure (0.7 ± 0.3 versus 0.9 ± 0.5 mmol/
100 g/min, p = 0.47). Glucose uptake rates in VAT (1.8 ± 0.7
versus 1.8 ± 0.5 mmol/100 g/min, p = 0.91) and skeletal muscleCel(0.7 ± 0.2 versus 0.7 ± 0.3 mmol/100 g/min, p = 0.26) also
remained unchanged. Glucose uptake results are summarized
in Figure 1D. These results indicate that the glucose uptake
rates in subcutaneous WAT, VAT, and skeletal muscle are quite
similar and unaffected by cold, while BAT glucose uptake can be
stimulated significantly by cold exposure.
Cold exposure significantly increased concentrations of
norepinephrine in plasma (1.9 ± 0.5 versus 4.9 ± 1.5 nmol/l,
p < 0.0001) (Figure S1A), but no significant associations were
found between activation of BAT by cold and the concentrations
of norepinephrine, its metabolite dihydroxyphenylglycol (DHPG),
or cyclic adenosine monophosphate (cAMP) in plasma. On the
other hand, cold exposure decreased plasma insulin concentra-
tion (4.1 ± 1.8 versus 2.2 ± 1.0 mU/l, p < 0.001) (Figure S1E).
Effect of Insulin on Glucose Uptake
Insulin is a major regulator of glucose uptake in most tissues. As
little is known about the insulin sensitivity of human BAT, we
assessed the influence of insulin on BAT, WAT, and skeletal
muscle glucose uptake (Figure 1D). The insulin-stimulated glu-
coseuptake rate in thesupraclavicular adipose tissue (Figure1C),
identified to contain cold-activated BAT, was 5-fold higher than
when studied without insulin stimulation (0.9 ± 0.4 versus 4.7 ±
2.4 mmol/100 g/min, p < 0.001, control versus insulin stimulation,
respectively) and not significantly different from that in skeletal
muscle (6.0±2.5mmol/100g/min, p=0.19). Insulinalsoenhanced
glucose uptake in subcutaneous abdominal WAT (0.7 ± 0.3
versus 1.9 ± 0.6 mmol/100 g/min, p < 0.0001) and VAT (1.8 ± 0.7l Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Inc. 273
Figure 2. Perfusion and Glucose Extraction
(A) PET/CT image showing unaffected perfusion in the supraclavicular BAT under control conditions.
(B) PET/CT image after cold exposure showing increased perfusion in the supraclavicular BAT.
(C) PET/CT image showing unaffected perfusion in the supraclavicular BAT during insulin stimulation.
(D) Perfusion of BAT, subcutaneous neck WAT, and skeletal muscle determined under control conditions, during cold exposure, and during insulin stimulation.
Results are expressed as means ± SD. ***p < 0.001.
(E) Glucose extraction of BAT, subcutaneous neck WAT, and skeletal muscle determined under control conditions, during cold exposure, and during insulin
stimulation. Results are expressed as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
(F) Relationship between cold-activated perfusion and glucose uptake rate in the supraclavicular adipose tissue.
(G) Association of supraclavicular adipose tissue perfusion and whole-body energy expenditure.
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remained lower than in BAT (p = 0.003 and p = 0.01, subcuta-
neous WAT and VAT, respectively). The subjects who lacked
cold-activated BAT showed insulin-mediated glucose uptake in
the supraclavicular adipose tissue depot (1.9 ± 0.1 mmol/100 g/
min) similar to that in subcutaneous abdominal WAT.
Relationship between Perfusion and Metabolism
BAT is highly vascularized. The blood flow provides oxygen for
BAT mitochondria, and also transfers heat from BAT to other274 Cell Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Incparts of the body. We quantified perfusion in supraclavicular
BAT, subcutaneous neck WAT, and skeletal muscle (Figures
2A–2C).
The BAT perfusion more than doubled in response to cold
(7.5 ± 3.7 versus 15.9 ± 4.9 ml/100 g/min, p = 0.0002), while no
changes were observed in subcutaneous WAT (3.0 ± 1.6 versus
3.7 ± 2.0 ml/100 g/min, p = 0.18) or in skeletal muscle (3.8 ± 3.6
versus 2.0 ± 1.1 ml/100 g/min, p = 0.08) (Figure 2D). Subse-
quently, glucose extraction from blood was determined (Fig-
ure 2E). Cold exposure increased glucose extraction from blood.
Table 1. Division of Subjects by Cold Activation of BAT
Cold-Activated
BAT
No Cold
Activation P value
Age (years) 38.7 ± 10.0 41.5 ± 9.7 0.514
BMI (kg/m2) 22.7 ± 2.2 22.7 ± 2.6 0.981
Waist (cm) 75.2 ± 8.6 77.8 ± 7.3 0.466
M value (mmol/kg/min) 47.6 ± 22.5 45. 8 ± 18.1 0.858
Plasma thyroid-stimulating
hormone (mU/l)
2.9 ± 1.8 1.7 ± 0.8 0.039
Free plasma thyroxine (pmol/l) 14.9 ± 2.2 14.8 ± 2.6 0.885
Free plasma triiodothyronine
(pmol/l)
4.8 ± 0.6 4.5 ± 0.5 0.300
Measurements in Cold
Exposure
n = 19 n = 8 n/a
Plasma thyroid-stimulating
hormone (mU/l)
2.1 ± 1.3 1.4 ± 0.5 0.220
Free plasma thyroxine
(pmol/l)
14.4 ± 2.0 14.9 ± 3.3 0.730
Free plasma triiodothyronine
(pmol/l)
4.5 ± 0.7 4.5 ± 0.8 0.984
Plasma norepinephrine
(nmol/l)
5.5 ± 2.6 5.0 ± 1.5 0.572
Plasma DHPG (nmol/l) 14.8 ± 7.1 13.2 ± 3.9 0.543
Plasma cAMP (nmol/l) 17.7 ± 5.6 17.9 ± 4.1 0.930
Plasma insulin (mU/l) 2.2 ± 1.1 2.2 ± 0.8 0.936
Plasma lactate (mmol/l) 1.0 ± 0.4 0.9 ± 0.2 0.224
Energy expenditure (MJ/24 hr) 6.7 ± 0.9 6.1 ± 0.8 0.109
Respiratory quotient 0.83 ± 0.17 0.80 ± 0.03 0.641
Measurements under
Control Conditions
n = 8 n = 4 n/a
Plasma norepinephrine
(nmol/l)
2.0 ± 0.6 1.8 ± 0.3 0.645
Plasma DHPG (nmol/l) 8.0 ± 1.3 7.3 ± 1.7 0.403
Plasma cAMP (nmol/l) 13.4 ± 2.3 13.8 ± 2.5 0.790
Plasma insulin (mU/l) 5.3 ± 3.3 3.8 ± 1.3 0.403
Energy expenditure (MJ/24 hr) 5.5 ± 0.4 5.4 ± 0.5 0.655
Respiratory quotient 0.79 ± 0.03 0.82 ± 0.01 0.212
Measurements in Insulin
Stimulation
n = 11 n = 3 n/a
Plasma norepinephrine
(nmol/l)
2.2 ± 0.9 3.0 ± 1.5 0.299
Plasma DHPG (nmol/l) 10.1 ± 2.9 13.4 ± 7.8 0.279
Plasma cAMP (nmol/l) 13.3 ± 4.1 16.4 ± 4.1 0.263
Plasma insulin (mU/l) 68.6 ± 11.3 68.7 ± 7.8 0.997
Energy expenditure (MJ/24 hr) 6.3 ± 0.6 5.8 ± 0.3 0.200
Respiratory quotient 0.92 ± 0.03 0.93 ± 0.05 0.634
The subjects have been divided into two groups, ‘‘Cold-Activated BAT’’
and ‘‘No Cold Activation,’’ based on cold exposure PET/CT findings.
Values are expressed as means ± SD.
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subcutaneous WAT. The glucose extraction in skeletal muscle
was also slightly increased by cold exposure (0.3 ± 0.1 versus
0.4 ± 0.2 mmol/ml, p = 0.03). The glucose uptake rate and perfu-
sion in the supraclavicular adipose tissue were associated in
a curvilinear fashion during cold exposure (r = 0.822, p < 0.001)
(Figure 2F). Interestingly, a positive association was found
between BAT perfusion and whole-body energy expenditure
(r = 0.449, p = 0.021) during cold exposure (Figure 2G).
The effect of insulin on BAT perfusion and glucose extraction
was also tested. Hyperinsulinemic euglycemia did not enhance
perfusion in BAT (7.5 ± 3.7 versus 6.1 ± 4.0 ml/100 g/min, p =
0.38), WAT (3.0 ± 1.6 versus 3.9 ± 2.9 ml/100 g/min, p = 0.35),
or skeletal muscle (3.8 ± 3.6 versus 2.7 ± 1.6 ml/100 g/min,
p = 0.34) (Figure 2D). Glucose extraction was significantly
increased by insulin both in BAT (0.1 ± 0.1 versus 1.0 ±
0.5 mmol/ml, p = 0.002) and in skeletal muscle (0.3 ± 0.1 versus
2.6 ± 1.2 mmol/ml, p < 0.0001) (Figure 2E).
Differences between Subjects with and without
Active BAT
Concentrations of thyroid-stimulating hormone (TSH) and the
thyroid hormones free triiodothyronine (T3) and free thyroxine
(T4) in plasma were measured in conjunction with screening
and cold exposure. TSH was slightly higher among the subjects
with cold-activated BAT (2.9 ± 1.8 versus 1.7 ± 0.8 mU/l,
p = 0.039). Plasma TSH concentrations usually rise with age, but
in our material, subjects with active BAT tended to be younger
than those without active BAT. No differences were detected
in the screening values of free T4 (14.9 ± 2.2 versus 14.8 ±
2.6 pmol/l, p = 0.885) or free T3 (4.8 ± 0.6 versus 4.5 ±
0.5 pmol/l, p = 0.300). Plasma TSH was decreased in response
to cold, while free plasma T3 was slightly decreased only among
subjects with active BAT (Figures S1C and S1D).
During cold exposure, normalized whole-body energy expen-
diture tended to be higher in subjects with active BAT (6.7 ± 0.9
versus 6.1 ± 0.8 MJ/24 hr, p = 0.109).
We did not observe significant differences in whole-body
insulin-stimulated glucose uptake (M value), fasting plasma
glucose, oral glucose tolerance, or body mass index (BMI).
Measurements are summarized in Table 1.
Gene Expression in BAT and WAT
Little is known about the expression levels of genes related to
insulin signaling and glucose uptake in human BAT. Hence, we
analyzed the levels of some important players in these events
by quantitative real-time PCR and compared the expression
levels in BAT to those in WAT (Figure 3). The only gene that was
found to be differently expressed in BAT versus WAT was
GLUT4, which was significantly more highly expressed in BAT.
While a trend toward higher expression of GLUT1 and lower
expression of IRS1 in BAT versus WAT was seen, neither IRS2
nor INSR showed any signs of being differently expressed in the
two tissues. Thehigher expression ofGLUT4 in BATascompared
toWATmight partly explain the higher insulin-stimulated increase
in glucose uptake rate in BAT than in subcutaneous WAT. The
UCP1 expression levels were determined as a control for BAT
versus WAT identity, and they were confirmed to be several-
fold higher in BAT as compared to WAT samples (Figure 3).CelDISCUSSION
Only a few studies on the existence of BAT in healthy adults have
been published. The main objective of this study was to quantifyl Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Inc. 275
Figure 3. Expression of Glucose Uptake-Related Genes
in WAT versus BAT
The relative expression levels of five genes involved in insulin
signaling and glucose uptake (GLUT1, GLUT2, IRS1, IRS2, and
INSR) were measured in WAT and BAT samples from seven
subjects. To validate the BAT versus WAT identity of the samples,
their UCP1 expression levels were measured and confirmed to
be several-fold higher in BAT as compared to WAT. Each of the
seven subjects is labeled with a number (1–7).
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how these parameters respond to cold exposure and increased
insulin levels.276 Cell Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Inc.Blood flow in the human supraclavicular BAT has
not been studied before. Our observation of increased
perfusion in BAT in response to cold reflects the dense
vasculature of the tissue. The association we could
show between BAT perfusion and glucose uptake
rate is actually very similar to the response seen in
exercising skeletal muscle (Pearson’s r = 0.636, p <
0.01, data not shown).
We found that the concentrations of norepinephrine
and its main metabolite, DHPG, were substantially
increased in plasma during cold exposure. However,
similar increases in these biomarkers, thought to
reflect sympathetic nervous system activation, were
seen both in subjects with and without cold-activated
BAT. This suggests that the subjects who fail to acti-
vate BAT in response to this treatment either require
more pronounced stimulation or lack BAT altogether.
The latter view is supported by the finding that the
subjects who lacked cold-activated BAT showed
insulin-mediated glucose uptake in the supraclavicular
adipose depot similar to that in subcutaneous WAT,
while the BAT of subjects with cold-activated BAT
was highly insulin sensitive since its insulin-stimulated
glucose uptake rate was not significantly different from
that of skeletal muscle.
Plasma insulin was decreased by cold exposure.
This may suggest that insulin is not a significant player
in the norepinephrine-driven acute cold-induced ther-
mogenesis. It has been demonstrated using hiber-
noma-derived tumor cells that norepinephrine-in-
duced expression of UCP1 mRNA is dependent on
insulin only during prolonged culture periods (Kozak
et al., 1992). Studies on streptozotocin-treated mice
suggest that insulin deficiency progressively de-
creases the thermogenic capacity of BAT (Shibata
et al., 1987). Shibata et al. also showed that insulin
administration does not acutely restore the thermo-
genic response of BAT.
Although insulin infusion stimulates glucose uptake
in WAT, the glucose uptake rate remains much lower
than in BAT. Our gene expression analysis of human
adipose tissue showed that GLUT4 is more abun-
dantly expressed in BAT as compared to WAT, a
feature that might partly explain why BAT seems to
be a more insulin-sensitive tissue than WAT. Duringhyperinsulinemic euglycemia, we did not detect increased perfu-
sion in BAT, showing that the insulin-mediated activation of
BAT metabolism is not dependent on increased perfusion. This
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oxygen demand during insulin-stimulated thermogenesis, or
because the glucose is only transported into the brown
adipocytes and no thermogenesis takes place. During hyper-
insulinemic euglycemia, we did not observe increased plasma
norepinephrine levels, although plasma concentration of DHPG
was slightly elevated. Insulin has been shown to increase
plasma norepinephrine when infused at 15-fold concentration
compared to our study (Kern et al., 2005), and an insulin
infusion comparable to our study has been shown to increase
skeletal muscle sympathetic nerve activity (Bisquolo et al.,
2005). Hence, we conclude that although we did not observe
increased plasma norepinephrine levels, it cannot be excluded
that the sympathetic nerve activity is increased in BAT during
hyperinsulinemic euglycemic clamp. It seems that the mecha-
nism behind BAT activation by insulin infusion is distinct from
cold activation, since cold exposure decreases plasma insulin
concentration.
Insulin stimulates glucose uptake in brown adipocyte cell
models (Klein et al., 2002) and in rodent BAT (Inokuma et al.,
2005). That the presence of insulin-sensitive BATwould be bene-
ficial for whole-body metabolism is supported by results from
studies on genetically modified mice having increased amounts
of BAT (Cederberg et al., 2001; Seale et al., 2011). However,
skeletal muscle would clearly remain the organ determining
whole-body insulin-stimulated glucose disposal rate in adult hu-
mans, even if BAT was expanded considerably. Our aim was to
explore the normal physiology of BAT. Therefore, a rather homo-
geneous group of healthy subjects with normal glucose toler-
ance and a limited range of BMI were included in the study.
The probability of detecting significant differences between
subjects with and without active BAT was therefore rather small.
Nevertheless, subjects with active BAT did tend to have higher
whole-body energy expenditure during cold exposure. Further-
more, we found that perfusion in BAT is positively associated
with whole-body energy expenditure during cold exposure,
unlike, e.g., plasma concentrations of thyroid hormones or cate-
cholamines (Table S1). It has been estimated that BAT thermo-
genesis accounts for 40% of total oxygen consumption in
cold-acclimated rats during cold exposure (Foster and Frydman,
1979). Our results suggest that active BAT induces an increase
in energy expenditure in a perfusion-dependent manner in
humans. A recent study has shown an association between the
cold-induced rise in energy expenditure and BAT activity (Yone-
shiro et al., 2011). These findings indicate a role for BAT in human
energy homeostasis.
Plasma TSH was found to be significantly elevated among
subjects with cold-activated BAT. TSH receptors are present in
adipose tissue (Sorisky et al., 2008), and interestingly, TSH
receptor activation has been linked to an increase in UCP1
expression in preadipocytes (Zhang et al., 2006). Therefore,
TSH may promote formation of BAT. On the other hand, TSH
concentration was decreased by cold exposure (Figure S1C),
and free plasma T3 in BAT-positive subjects was also slightly
decreased (Figure S1D). In contrast, active BAT in rodents
appears to generate T3 for the plasma pool (Silva and Larsen,
1985). However, it should be pointed out that complex interac-
tions between BAT and thyroid hormones are unlikely to be
proven bymeasuring plasma concentrations of these hormones.CelIn conclusion, both glucose uptake and perfusion are
increased in human BAT in response to cold, indicating active
thermogenesis. We also show that human BAT is a highly
insulin-sensitive tissue type and that its insulin-stimulated
uptake of glucose is not dependent on increased perfusion.
Our findings on cold-activated perfusion and insulin-mediated
glucose uptake in human BAT reinforce the view that BAT plays
a role in human metabolism.
EXPERIMENTAL PROCEDURES
Subjects
All subjects (age 40.2 ± 9.4 years, BMI 22.8 ± 2.2 kg/m2, 20 females and
7 males) provided written informed consent. The study protocol was reviewed
and approved by the Ethics Committee of the Hospital District of Southwest
Finland, and the study was conducted according to the principles of the
Declaration of Helsinki. The subjects were screened for medical history and
status, and those who were healthy and had normal glucose tolerance and
cardiovascular status, as assessed on the basis of routine laboratory tests,
2 hr oral glucose tolerance test, electrocardiograms, and measured blood
pressure, were enrolled in the study.
Study Design
The subjects underwent two PET/CT sessions on separate days after over-
night fasting. One session was performed during cold exposure and the other
either with or without insulin stimulation in a warm environment. The first 12
subjects were assigned to a group without insulin stimulation and the next
15 subjects to a group receiving insulin stimulation. One subject in the latter
group attended only the cold exposure session and withdrew from the study
before the insulin stimulation.
On the cold exposure day, the subjects spent 2 hr wearing light clothing in
a room with an ambient temperature of 17C ± 1C before moving into the
PET/CT room, which had an air temperature of 23C. During the PET/CT
session, one foot of the subject was placed intermittently (5 min in/5 min
out) in cold water at a temperature of 8C ± 1C. The small temperature
fluctuations in the prescan room and cold water bath did not affect the
glucose uptake in BAT during the PET/CT sessions (Figure S2). On the insulin
stimulation day, plasma insulin was increased using a primed-continuous
(1 mU $ kg1 $ min1) infusion of insulin (Actrapid, Novo Nordisk A/S), and
normoglycemia was maintained with an infusion of 20% glucose adjusted
according to plasma glucose measurements (DeFronzo et al., 1979). In the
control group, isotonic saline was infused instead. Whole-body energy expen-
diture was measured with an indirect calorimeter (Deltatrac II, Datex-Ohmeda)
during the PET/CT sessions. Energy expenditure was normalized to fat-free
mass, measured with a bioimpedance-based method (Omron BF400, Omron
Healthcare).
Biopsy Procedure
Seven subjects provided an additional written informed consent for a biopsy
of supraclavicular adipose tissue to be performed. The site of the biopsy
was decided by the cold exposure [18F]FDG-PET/CT image that showed acti-
vated BAT. A subcutaneous WAT sample was collected from the same inci-
sion. The biopsies were obtained under local lidocaine-epinephrine anesthesia
by a plastic surgeon at normal room temperature (20C). Immediately after
removal, the tissue samples were snap-frozen in liquid nitrogen.
PET Scanning Protocol
PET/CT (GE Discovery VCT) scanning began from the clavicular region, the
level of clavicles being in the middle of the axial field of view (AFOV). First,
a 900 MBq bolus of [15O]H2O was administered intravenously, and a dynamic
emission scan with variable frame lengths (6 3 5 s, 6 3 15 s, 8 3 30 s) was
performed to determine tissue perfusion. After sufficient decay of [15O]H2O,
a 185 MBq bolus of the glucose analog [18F]FDG was administered, and a
dynamic emission scan with variable frame lengths (1 3 1 min, 6 3 0.5 min,
1 3 1 min, 3 3 5 min, 23 10 min) was started simultaneously in the clavicular
region. Next, the AFOVwas placedmore caudally on the lower thoracic region,l Metabolism 14, 272–279, August 3, 2011 ª2011 Elsevier Inc. 277
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formed. Third, the AFOV was placed even more caudally to the abdominal
region, and a dynamic emission scan was performed again with constant
frame lengths (5 3 3 min).
PET Analysis
The regions of interest (ROIs) were manually outlined in the fusion image,
composed of summed dynamic [18F]FDG PET image and the CT image. The
glucose uptake rate value was based on ROIs drawn on 2–3 adjacent trans-
axial planes on both lateral aspects for defined structures of supraclavicular
BAT and deltoid muscle and, in the case of abdominal subcutaneous WAT,
on planes superior to the umbilicus. Posterior subcutaneous neck WAT was
outlined in the midline and VAT at the level of the umbilicus. Subsequently,
regional time activity curves (TACs) were generated.
Regional TAC data were analyzed against current radioactivity in arterial
plasma using the model of Patlak (Patlak and Blasberg, 1985). A lumped
constant value of 1.14 was used for adipose tissue (Virtanen et al., 2001)
and of 1.20 for skeletal muscle (Peltoniemi et al., 2000). The glucose extraction
was determined by dividing the glucose uptake rate with the corresponding
perfusion rate.
The method of measuring tissue perfusion with [15O]H2O is based on the
principle of exchange of inert gas between blood and tissues (Kety and
Schmidt, 1945). A two-compartment model including fractional arterial blood
volume (de Langen et al., 2008) was linearized and fitted with the subject’s
whole-blood input function to PET data voxel-by-voxel using the Lawson-
Hanson nonnegative least-squares technique to produce parametric perfusion
images. The kinetic modeling allows exact quantification even in the presence
of flow heterogeneity and nonuniform partition coefficient of water. ROIs of
regional glucose uptake analysis were employed in the determination of
perfusion.
RNA Preparation, cDNA Synthesis, and Quantitative Real-Time PCR
Total RNA was isolated from the attained biopsies and used for cDNA
synthesis as previously published (Virtanen et al., 2009). Quantitative real-
time PCR reactions were performed using the Power SYBRGreen PCRMaster
Mix (Applied Biosystems) and an ABI PRISM 7900HT machine (Applied
Biosystems). Relative gene expression levels were determined by the stan-
dard curve method using b-actin as the normalizing gene. The primers used
in this study are found in Table S2.
Statistical Analyses
Results are expressed as means ± SD. Two-tailed paired and unpaired
Student’s t tests were applied to test the statistical significance of differences
between the results recorded under control conditions, during cold exposure,
and during insulin stimulation. Differences between subjects with and without
cold-activated BAT were evaluated with unpaired t test. Gene expression
levels in WAT versus BATwere analyzed usingWilcoxonmatched pairs signed
ranks test.
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